RNA-U6 small nuclear 876 as a potential drug target or biomarker

Target Name: RNU6-876P

NCBI ID: G106481455

RNU6-876P

Other Name(s): RNA, U6 small nuclear 876, pseudogene

RNA-U6 small nuclear 876 as a potential drug target or biomarker

RNA-U6 small nuclear 876 (RNU6-876P) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a small molecule that is expressed in all cell types and is highly stable in the cell. RNU6-876P has been shown to play a role in a variety of cellular processes, including cell growth, apoptosis, and transcriptional regulation.

One of the key features of RNU6-876P is its small size and stability. It has a molecular weight of only 762 Da and has a reported dissociation constant (Kd) of 1.9 nM, which suggests that it is a weakly bound protein. This stability and low mobility have made it difficult to study using techniques such as mass spectrometry, which requires high-resolution mass tags and strong signals.

Despite its small size, RNU6-876P is able to undergo important cellular processes. For example, it has been shown to play a role in cell apoptosis, which is the process by which cells die when they are no longer needed. Studies have shown that RNU6-876P can induce cell apoptosis in a variety of cell types, including cancer cells. This suggests that it may be a useful drug target or biomarker for diseases that are characterized by uncontrolled cell growth and apoptosis.

In addition to its role in cell apoptosis, RNU6-876P has also been shown to play a role in cell transcriptional regulation. This is the process by which cells use RNA to create the proteins that they need to carry out their functions. Studies have shown that RNU6-876P can interact with the protein p21, which is a key regulator of cell apoptosis. This interaction suggests that RNU6-876P may be a useful drug target or biomarker for diseases that are characterized by disruptions in protein synthesis and apoptosis.

Another potential use of RNU6-876P is as a diagnostic biomarker. Its stable expression and low mobility make it difficult to detect and quantify in a cell-based assay, which could limit its utility as a biomarker. However, there are studies showing that RNU6-876P can be detected in various biological samples, including blood and tissue, and that it is able to provide information about cellular processes such as cell cycle, apoptosis, and transcriptional regulation. This suggests that it may be a useful diagnostic biomarker in a variety of diseases.

In conclusion, RNU6-876P is a small non-coding RNA molecule that has been shown to play a role in a variety of cellular processes, including cell growth, apoptosis, and transcriptional regulation. Its stability and low mobility make it difficult to study using techniques such as mass spectrometry, but its ability to induce cell apoptosis and participate in cell transcriptional regulation make it a potential drug target or biomarker. Further research is needed to fully understand its role in cellular processes and its potential as a diagnostic biomarker.

Protein Name: RNA, U6 Small Nuclear 876, Pseudogene

The "RNU6-876P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU6-876P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets